Instrument Inactif

Communiqués Intellego Technologies AB

Actions

INT

SE0016075063

Recherche biotechnologique et médicale

Communiqués

08/04	Notice of extraordinary general meeting and first control meeting of Intellego Technologies AB (publ)	AQ
04/03	Decision on delisting from the Nasdaq First North Growth Market trading platform will be executed on 4 March 2026	AQ
04/03	The Disciplinary Committee of Nasdaq Stockholm has decided to delist the shares in Intellego Technologies AB (publ) from Nasdaq First North Growth Market	AQ
26/02	The board of directors of Intellego Technologies AB (publ) resolves on staff cuts	AQ
23/02	The board of directors of Intellego Technologies AB (publ) dismisses the CEO	AQ
23/02	Bulletin from the extraordinary general meeting of Intellego Technologies AB (publ)	AQ
20/02	Financial Statements from Intellego Technologies AB 2025	AQ
19/02	Follow-up independent forensic report concerning 2024 Leads Intellego to File an Additional Criminal Complaint Against Former CEO	AQ
18/02	Invitation to presentation of Financial Statements 2025 – Intellego Technologies AB	AQ
16/02	Proposed new board of directors for the extraordinary general meeting of Intellego Technologies AB	AQ
30/01	Independent forensic investigation of Intellego Technologies’ financial information and corporate communication presented today	AQ
20/01	Nasdaq requests Disciplinary Committee to delist Intellego	AQ
15/01	Clarification regarding Intellego Technologies' police report against its former CEO and founder	AQ
12/01	INVITATION TO PRESS BRIEFING – PRESENTATION OF KPMG’S CONCLUSIONS FROM THE INVESTIGATION OF INTELLEGO	AQ
12/01	Intellego files a police report on former CEO	AQ
12/01	NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTELLEGO TECHNOLOGIES AB (PUBL)	AQ
03/01	Intellego announces cancellation of MoveoMed transaction	AQ
30/12	Intellego’s partner HAI Solutions has received FDA approval for QIKcap	AQ
18/12	Update from Intellego	AQ
17/12	Board Member Johan Möllerström refrains from performing his duties during the investigation period	AQ
17/12	Heights Capital Management poses claim on Intellego Technologies AB	AQ
15/12	Intellego Technologies’ board member Johan Möllerström has been notified of suspicion of gross fraud	AQ
10/12	Intellego appeals asset freeze	AQ
04/12	Intellego granted additional time to respond to Nasdaq	AQ
27/11	Deloitte AB intends to submit a report of suspicion of accounting fraud	AQ